These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 9141800)

  • 21. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
    Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
    Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemostatic profile of children with nephrotic syndrome attending University of Nigeria Teaching Hospital Ituku-Ozalla, Nigeria.
    Odimegwu CL; Ikefuna AN; Okafor HU; Nwagha T; Ubesie A; Chinawa JM
    BMC Nephrol; 2022 Aug; 23(1):274. PubMed ID: 35927678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clotting profile in cattle showing chronic enzootic haematuria (CEH) and bladder neoplasms.
    Di Loria A; Piantedosi D; Cortese L; Roperto S; Urraro C; Paciello O; Guccione J; Britti D; Ciaramella P
    Res Vet Sci; 2012 Aug; 93(1):331-5. PubMed ID: 21839485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thromboembolic complications in nephrotic syndrome].
    Maurin N
    Dtsch Med Wochenschr; 2013 May; 138(21):1123-9. PubMed ID: 23677507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the hypercoagulable state by measuring protein C and antithrombin III levels in nephrotic syndrome and in familial Mediterranean fever-related amyloidosis.
    Topaloğlu R; Saatçi U; Bakkaloğlu A; Beşbaş N; Başsoy Y
    Turk J Pediatr; 1992; 34(1):15-20. PubMed ID: 1509525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective study on plasma clotting parameters in diabetic children--no evidence for specific changes in coagulation system.
    Zeitler P; Thiede A; Müller HL
    Exp Clin Endocrinol Diabetes; 2001; 109(3):146-50. PubMed ID: 11409296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Univariate tolerance regions for fibrinogen, antithrombin III, protein C, protein S, plasminogen and alpha 2-antiplasmin in children using the new Automated Coagulation Laboratory (ACL) method.
    Nowak-Göttl U; Funk M; Mosch G; Wegerich B; Kornhuber B; Breddin HK
    Klin Padiatr; 1994; 206(6):437-9. PubMed ID: 7529848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Complications of nephrotic syndrome with special reference to thromboembolic accidents].
    Kuhlmann U; Blättler W; Pouliadis G; Siegenthaler W
    Schweiz Med Wochenschr; 1979 Feb; 109(6):200-9. PubMed ID: 370977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemostatic measurements in childhood nephrotic syndrome.
    Elidrissy AT; Abdurrahman MB; Bahakim HM; Jones MD; Gader AM
    Eur J Pediatr; 1991 Mar; 150(5):374-8. PubMed ID: 2044614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thromboembolic risk in children with nephrotic syndrome.
    De Mattia D; Penza R; Giordano P; Di Bitonto G; Altomare M; Del Vecchio GC; Schettini F
    Haemostasis; 1991; 21(5):300-4. PubMed ID: 1806458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coagulation inhibitors in preeclamptic pregnant women.
    Osmanağaoğlu MA; Topçuoğlu K; Ozeren M; Bozkaya H
    Arch Gynecol Obstet; 2005 Mar; 271(3):227-30. PubMed ID: 14735372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of selected parameters of hemostasis in patients with nephrotic syndrome].
    Rowiński M; Rydzewski A; Małyszko JS; Małyszko J; Myśliwiec M
    Przegl Lek; 1994; 51(2):77-81. PubMed ID: 8058973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the host response in human Plasmodium falciparum malaria: relation of parasitemia to tumor necrosis factor/cachectin, thrombin-antithrombin III, and protein C levels.
    Hemmer CJ; Kern P; Holst FG; Radtke KP; Egbring R; Bierhaus A; Nawroth PP; Dietrich M
    Am J Med; 1991 Jul; 91(1):37-44. PubMed ID: 1858827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of serum interleukin-7 concentration and the coagulation state in children with nephrotic syndrome.
    Wasilewska A; Zoch-Zwierz WM; Tomaszewska B; Zelazowska B
    Pediatr Int; 2005 Aug; 47(4):424-9. PubMed ID: 16091081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Thrombosis and disorders of hemostasis in nephrotic syndrome].
    Kanfer A
    Nephrologie; 1992; 13(4):151-7. PubMed ID: 1407255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
    Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanism of renal vein thrombosis in patients with nephrotic syndrome: a prospective study].
    Cheng H
    Zhonghua Yi Xue Za Zhi; 1992 Jul; 72(7):416-9, 447. PubMed ID: 1330232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thrombotic complications in the nephrotic syndrome].
    Keusch G
    Schweiz Med Wochenschr; 1989 Aug; 119(31-32):1080-5. PubMed ID: 2678444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Features of thrombophilia in nephrotic syndrome in children].
    Serebrianyĭ VL; Ignatova MS; Degtiareva EM; Svetlov SI
    Pediatriia; 1989; (1):49-53. PubMed ID: 2710603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.